MapWatchScheduleDaily RecordMembersCommitteesLegislationNominationsMoneySpecial RulesSubpoenasHouse EthicsForeign InfluenceAgenciesRegulationsOffice SpendingUS Code

Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Search⌘K
MapWatchScheduleDaily RecordMembersCommitteesLegislationNominationsMoneySpecial RulesSubpoenasHouse EthicsForeign InfluenceAgenciesRegulationsOffice SpendingUS Code

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
8,262
Regulations.gov

Showing 30 of 8,262 dockets

Nonrulemaking
FDA

FDA-2025-H-6447

DAB Civil Money Penalty; Susan R. Gherna d/b/a Phoenix Store; CLOSED 02/12/2026

1 docNo comments
Nonrulemaking
NRC

NRC-2022-0201

Notice of Intent to Conduct Scoping Process and Prepare Supplement to Draft Environmental Impact Statement TRISO-X Fuel Fabrication Facility

4 docs1.8K comments
Nonrulemaking
NRC

NRC-2026-0727

Constellation Energy Generation, LLC; LaSalle County Station, Units 1 and 2; License Amendment Request

1 docNo comments
Nonrulemaking
FDA

FDA-2025-E-0362

Patent Term Application for AUCATZYL (obecabtagene autoleucel), Patent No. 10,457,730

6 docsNo comments
Nonrulemaking
FDA

FDA-2025-H-7265

DAB Civil Money Penalty; Rose Tobacco & Vape 2 LLC, d/b/a Rose; CLOSED 02/12/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2024-E-3534

Patent Term Extension Application for AMTAGVI™ (lifileucel), Patent No. 11,291,687

6 docsNo comments
Nonrulemaking
FDA

FDA-2025-H-6582

DAB Civil Money Penalty; Fair Oaks Quick Mart, Inc. d/b/a Gulf / Fair Oaks Quick Mart; CLOSED 02/12/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2026-P-1636

Requests that the FDA determine whether Tovalt ODT (Zolpidem Tartrate), 5mg and 10mg Orally Disintegrating Tablets, New Drug Application 021412 had been voluntarily withdrawn from sale for safety or efficacy reasons.

2 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0360

Patent Term Application for ATTRUBY™ (acoramidis), Patent No. 10,842,777

6 docsNo comments
Nonrulemaking
FDA

FDA-2025-H-6857

DAB Civil Money Penalty; OSV Smoke & Vape Shop Inc. d/b/a O.S.V. Smoke & Vape; CLOSED 2/12/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2025-E-0359

Patent Term Application for ATTRUBY™ (acoramidis), Patent No. 10,398,681

6 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0358

Patent Term Application for ATTRUBY™ (acoramidis), Patent No. 9,913,826

6 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0357

Patent Term Application for ATTRUBY (acoramidis), Patent No. 9,642,838

6 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0508

Patent Term Extension Application for CRENESSITY™ (crinecerfont), Patent No. 11,730,739

6 docsNo comments
Nonrulemaking
CMS

CMS-2025-1427

Elimination of Cost-Sharing for full benefit dual-eligible Individuals Receiving Home and Community-Based Services (CMS-10344)

2 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0492

Patent Term Extension Application for CRENESSITY™ (crinecerfont), Patent No. 11,311,544

6 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2002-12590

Exemption/Rulemaking - United States Hang Gliding Association, Inc. (USHGA)

30 docsNo comments
Comments due Aug 7, 2008
Nonrulemaking
CMS

CMS-2025-1426

National Implementation of the Outpatient and Ambulatory Surgery Consumer Assessment of Healthcare Providers and Systems (OAS CAHPS) Survey (CMS-10500)

2 docs1 comment
Nonrulemaking
CMS

CMS-2025-1032

Medicare Advantage and Prescription Drug Program (CMS-10260)

2 docs9 comments
Nonrulemaking
FDA

FDA-2025-H-6793

DAB Civil Money Penalty; A&R Hickory, Inc. /b/a Citgo; CLOSED 2/12/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2025-E-0369

Patent Term Application for KEBILIDI® (eladocagene exuparvovec-tneq), Patent No. 10,898,585

6 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-0873

DAB Civil Money Penalty; Istore LLC, d/b/a Lucky Stop N Shop; CLOSED 02/12/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-2426

Patent Term Extension Application for BLUJEPA (gepotidacin mesylate), Patent No. 8,389,524

6 docsNo comments
Comments due Aug 13, 2026
Nonrulemaking
FDA

FDA-2025-H-2778

DAB Civil Money Penalty; McDowell 41 Inc. d/b/a It’s All Goodz Smoke & Vape; CLOSED 02/12/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2025-E-0361

Patent Term Application for AUCATZYL (obecabtagene autoleucel), Patent No. 11,578,126

6 docsNo comments
Rulemaking
USCG

USCG-2026-0026

Special Local Regulations; Recurring Marine Events, Sector St. Petersburg

2 docsNo comments
Nonrulemaking
FDA

FDA-2024-E-3532

Patent Term Extension Application for AMTAGVI™ (lifileucel), Patent No. 10,639,330

6 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-0519

DAB Civil Money Penalty; Springer & Moore, LLC, d/b/a B & L's Drive Thru; CLOSED 02/12/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2025-E-0483

Patent Term Extension Application for ALYFTREK™ (vanzacaftor/tezacaftor/deutivacaftor), Patent No. 8,865,902

6 docsNo comments
Rulemaking
OSHA

OSHA-2019-0001

OSHA Update to the Hazard Communication Standard - 2019

318 docs171 comments
  • Previous
  • Page 272 of 276
  • Next